Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL9102789

N[C@H](C=CC(=O)O)CCc1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC15A1 P46059 1/20 0.51
CTSL P07711 1/20 0.42
ERAP1 Q9NZ08 4/20 0.42
ANPEP P15144 3/20 0.42
ERAP2 Q6P179 3/20 0.42
ACE P12821 1/20 0.41
CES1 P23141 5/20 0.40
FAAH O00519 3/20 0.40
ALDH1A1 P00352 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
HCAR2 Q8TDS4 1/20 0.40
LAP3 P28838 3/20 0.39
CPA1 P15085 1/20 0.39
ALPI P09923 1/20 0.39
PKM P14618 1/20 0.39
PTGS1 P23219 1/20 0.39
XIAP P98170 1/20 0.39
SLC7A5 Q01650 1/20 0.39
MME P08473 1/20 0.39
KEAP1 Q14145 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL9102768 1.00 SLC15A1 (0.51) SLC15A1CTSLERAP1ANPEPERAP2
Trifluoroacetic Acid SCHEMBL9943876 1.00 SLC15A1 (0.51) SLC15A1CTSLERAP1ANPEPERAP2
SCHEMBL7416137 0.91 SLC15A1 (0.55) SLC15A1CTSLERAP1ANPEPERAP2
SCHEMBL3131714 0.91 SLC15A1 (0.55) SLC15A1CTSLERAP1ANPEPERAP2
SCHEMBL7416145 0.91 SLC15A1 (0.55) SLC15A1CTSLERAP1ANPEPERAP2
SCHEMBL7416141 0.91 SLC15A1 (0.55) SLC15A1CTSLERAP1ANPEPERAP2
Hydrochloric Acid SCHEMBL7363138 0.90 SLC15A1 (0.54) SLC15A1CTSLERAP1ANPEPERAP2
Hydrochloric Acid SCHEMBL7363142 0.90 SLC15A1 (0.54) SLC15A1CTSLERAP1ANPEPERAP2
Hydrochloric Acid SCHEMBL7363137 0.90 SLC15A1 (0.54) SLC15A1CTSLERAP1ANPEPERAP2
Trifluoroacetic Acid SCHEMBL27862747 0.85 CTSL (0.51) CTSLACEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142668-A1 CATHEPSIN C INHIBITORS GLAXO GROUP LIMITED (GB) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142668-A1 CATHEPSIN C INHIBITORS CTSE, CTSB, CTSS SLC15A1 2067/4885CTSL 13/4885ERAP1 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.